Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia-Reference-Cited by-同舟云学术

Pitavastatin demonstrates long-term efficacy, safety and tolerability in elderly patients with primary hypercholesterolaemia or combined (mixed) dyslipidaemia

Published:2012-01-23 Issue:1 Volume:20 Page:29-39
ISSN:2047-4873
Container-title:European Journal of Preventive Cardiology
language:en
Short-container-title:Eur J Prev Cardiolog

Author:

Stender Steen¹,Budinski Dragos²,Hounslow Neil²

Affiliation:

1. Department of Clinical Biochemistry, Gentofte University Hospital, University of Copenhagen, Hellerup, Denmark.

2. Kowa Research Europe Ltd, Wokingham, Berkshire, UK.

Publisher

Oxford University Press (OUP)

Subject

Cardiology and Cardiovascular Medicine,Epidemiology

Link

http://journals.sagepub.com/doi/pdf/10.1177/2047487312437326

Reference37 articles.

1. Plasma Lipoproteins and Apolipoproteins as Predictors of Cardiovascular Risk and Treatment Benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER)

2. Lipoprotein Management in Patients With Cardiometabolic Risk

3. The implications of a growing evidence base for drug use in elderly patients. Part 1. Statins for primary and secondary cardiovascular prevention

4. Fourth Joint Task Force of the European Society of Cardiology and other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts)

5. Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Mitigation of CXCL10 secretion by metabolic disorder drugs in microglial-mediated neuroinflammation;Journal of Neuroimmunology;2024-06

2. Dyslipidemia;Practical Cardiovascular Medicine;2022-01-14

3. Evaluation of the Pharmacokinetic Drug–Drug Interaction between Micronized Fenofibrate and Pitavastatin in Healthy Volunteers;Pharmaceutics;2020-09-12

4. An evaluation of pitavastatin for the treatment of hypercholesterolemia;Expert Opinion on Pharmacotherapy;2018-11-27

5. Pitavastatin: A Review in Hypercholesterolemia;American Journal of Cardiovascular Drugs;2017-01-27